Digitisation | August 21, 2025
Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Aims to become India’s leading cancer testing company
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Subscribe To Our Newsletter & Stay Updated
